These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 38672636)

  • 1. The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway.
    Zoi V; Kyritsis AP; Galani V; Lazari D; Sioka C; Voulgaris S; Alexiou GA
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway.
    Hamzehzadeh L; Atkin SL; Majeed M; Butler AE; Sahebkar A
    J Cell Physiol; 2018 Oct; 233(10):6530-6537. PubMed ID: 29693253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
    Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
    Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
    Maiti P; Plemmons A; Dunbar GL
    PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Akt signaling pathway: Exploiting curcumin's anticancer potential.
    Aliyari M; Hashemy SI; Hashemi SF; Reihani A; Kesharwani P; Hosseini H; Sahebkar A
    Pathol Res Pract; 2024 Sep; 261():155479. PubMed ID: 39068859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnological synergy of mangiferin and curcumin in modulating PI3K/Akt/mTOR pathway: a novel front in ovarian cancer precision therapeutics.
    Alharbi HM; Alqahtani T; Alamri AH; Kumarasamy V; Subramaniyan V; Babu KS
    Front Pharmacol; 2023; 14():1276209. PubMed ID: 38239204
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonizing effects of curcumin against mercury-induced autophagic death and trace elements disorder by regulating PI3K/AKT and Nrf2 pathway in the spleen.
    Zhao G; Qi L; Wang Y; Li X; Li Q; Tang X; Wang X; Wu C
    Ecotoxicol Environ Saf; 2021 Oct; 222():112529. PubMed ID: 34293585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling.
    Deswal B; Bagchi U; Kapoor S
    Anticancer Agents Med Chem; 2024; 24(2):146-156. PubMed ID: 37957871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway.
    Zhu X; Zhu R
    Onco Targets Ther; 2018; 11():3521-3531. PubMed ID: 29950857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcuma as an adjuvant in colorectal cancer treatment.
    Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
    Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.
    Coker-Gurkan A; Bulut D; Genc R; Arisan ED; Obakan-Yerlikaya P; Palavan-Unsal N
    Mol Biol Rep; 2019 Feb; 46(1):355-369. PubMed ID: 30467667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway.
    Chang M; Wu M; Li H
    Am J Transl Res; 2017; 9(12):5567-5575. PubMed ID: 29312508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways.
    Wang H; Zhang K; Liu J; Yang J; Tian Y; Yang C; Li Y; Shao M; Su W; Song N
    Front Oncol; 2021; 11():660712. PubMed ID: 33912467
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Feng L; Lu WH; Li QY; Zhang HY; Xu LR; Zang WQ; Guo WT; Li YF; Zheng WJ; Geng YX; Li Q; Liu YH
    Am J Chin Med; 2023; 51(5):1189-1209. PubMed ID: 37314412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment.
    Ahmad I; Hoque M; Alam SSM; Zughaibi TA; Tabrez S
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells.
    Maiti P; Scott J; Sengupta D; Al-Gharaibeh A; Dunbar GL
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
    Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells.
    Akkoç Y; Berrak Ö; Arısan ED; Obakan P; Çoker-Gürkan A; Palavan-Ünsal N
    Biomed Pharmacother; 2015 Apr; 71():161-71. PubMed ID: 25960232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Signaling Pathway by Curcumin in Osteosarcoma.
    Farnood PR; Pazhooh RD; Asemi Z; Yousefi B
    Curr Mol Pharmacol; 2023; 16(1):71-82. PubMed ID: 35400349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.